NanoVation Therapeutics Archives - Inside Precision Medicine

Inside Precision Medicine Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal

ribonicleic acid chain from which can be used to make RNA silencing treatments for conditions such as congenital melanocytic nevus syndrome

News & Features

Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal

September 19, 2024

Related Content

The End of the Beginning for Cell and Gene Therapy

The End of the Beginning for Cell and Gene Therapy

Researchers Uncover Cause of Severe Atherosclerosis in Type of Progeria

Researchers Uncover Cause of Severe Atherosclerosis in Type of Progeria

U.K.’s Huge Newborn Screening Study Takes Off

U.K.’s Huge Newborn Screening Study Takes Off

Reasons Behind Leukemia Susceptibility in People with Down Syndrome Uncovered

Reasons Behind Leukemia Susceptibility in People with Down Syndrome Uncovered